======= RXRB ======= == Gene Information == * **Official Symbol**: RXRB * **Official Name**: retinoid X receptor beta * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6257|6257]] * **UniProt**: [[https://www.uniprot.org/uniprot/P28702|P28702]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RXRB&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RXRB|Open PubMed]] * **OMIM**: [[https://omim.org/entry/180246|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the retinoid X receptor (RXR) family of nuclear receptors which are involved in mediating the effects of retinoic acid (RA). The encoded protein forms homodimers with the retinoic acid, thyroid hormone, and vitamin D receptors, increasing both DNA binding and transcriptional function on their respective response elements. This gene lies within the major histocompatibility complex (MHC) class II region on chromosome 6. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]. * **UniProt Summary**: Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE). {ECO:0000269|PubMed:1310259}. |Hormone recep| |zf-C4| |Nuc recep-AF1| |retinoic acid-responsive element binding| |retinoic acid receptor signaling pathway| |nuclear receptor activity| |steroid hormone receptor activity| |RNA polymerase II transcription factor complex| |response to retinoic acid| |steroid hormone mediated signaling pathway| |intracellular receptor signaling pathway| |hormone-mediated signaling pathway| |transcription initiation from RNA polymerase II promoter| |cellular response to steroid hormone stimulus| |DNA-templated transcription, initiation| |transcription coactivator activity| |RNA polymerase II regulatory region sequence-specific DNA binding| |response to steroid hormone| |response to acid chemical| |DNA-binding transcription activator activity, RNA polymerase II-specific| |transcription by RNA polymerase II| |cellular response to lipid| |cellular response to organic cyclic compound| |cellular response to hormone stimulus| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |DNA-binding transcription factor activity| |zinc ion binding| |response to lipid| |response to hormone| |response to organic cyclic compound| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |organic cyclic compound biosynthetic process| |response to endogenous stimulus| |positive regulation of transcription, DNA-templated| |response to oxygen-containing compound| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-2.15| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-2.06| |[[:results:exp11|CCCP 1μM R00 exp11]]|-1.89| |[[:results:exp70|INK128 0.2μM R02 exp70]]|-1.85| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|-1.82| |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|-1.78| |[[:results:exp153|SGC2096 2.6μM R03 exp153]]|-1.76| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|-1.71| |[[:results:exp249|Vinorelbine 0.001μM R05 exp249]]|-1.71| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|1.71| |[[:results:exp446|4-Nitroquinoline-1-oxide 0.5μM R08 exp446]]|1.76| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|1.84| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|2.03| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|2.46| |[[:results:exp512|Olaparib 4μM R08 exp512]]|2.55| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|3.98| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.416| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5131 * **Expression level (log2 read counts)**: 5.59 {{:chemogenomics:nalm6 dist.png?nolink |}}